Camilla Dalby Hansen, EASL ILC 2022: Non-calorie restricted, low carbohydrate, high fat diet for NAFLD in T2DM

touchENDOCRINOLOGY spoke with Camilla Dably Hansen (Odense Hospital, Denmark) about the findings from the recent 6-month randomised controlled trial investigating the impact of a non-calorie restricted, low carbohydrate, high fat diet on nonalcoholic fatty liver disease (NAFLD) activity score (NAS) and HbA1c in patients with type 2 diabetes (T2DM).

The abstract entitled ‘A non-calorie restricted low carbohydrate high fat diet improves nonalcoholic fatty liver disease (NAFLD) activity score (NAS) and HbA1c in type 2 diabetes: a six-month randomised controlled trial’ (GS012) was presented at EASL ILC 2022, 22-26 June 2022.

Questions

1. What is known about the impact of diabetes status and glycemic control on the severity of nonalcoholic fatty liver disease (NAFLD)? (0:12)
2. What was the rationale for your study? (0:53)
3. Could you tell us a little about the methodology, eligibility criteria and clinical endpoints of the study? (1:49)
4. What were the findings of the study and what recommendations would you make on the basis of these findings? (2:46)

Disclosures: Camilla Dalby Hansen has nothing to disclose in relation to this video interview. 

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Gina Furnival. 

Filmed as a highlight of EASL ILC 2022